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Abstract
We present a case of 58-year-old woman with underlying diabetes mellitus, hepatitis C virus-
related liver cirrhosis, and total hysterectomy for uterine myoma 11 moths ago, who was
diagnosed ruptured aortic arch mycotic pseudoaneurysm after a certain period of survey for her
unknown fever cause. After emergent surgery with prosthetic graft interposition, all her blood
cultures and tissue cultures revealed pathogen with Bacteroides fragilis. Although mycotic aneurysms
have been well described in literatures, an aneurysm infected solely with Bacteroides fragilis is
unusual, with only eight similar cases in the literature. Here we reported the only female case with
her specific clinical and management course and summarized all reported cases of mycotic
aneurysm caused by Bacteroides fragilis to clarify their conditions and treatments, alert the difficulty
in diagnosis, and importance of highly suspicious.
Introduction
Aortic mycotic aneurysm of the thoracic aorta is a rare but
fulminant infectious disease and may potentially progress
to rupture and death unless early diagnosis and appropri-
ate treatment is instituted [1,2]. The early case reports
emphasized endocarditis as the most common source,
while hematogenous seeding, direct spreading from a
contiguous focus with trauma, lymphatic spreading, and
unknown etiology were proposed [1,3,4]. Staphylococcus
aureus, nontyphi Salmonella, and Pseudomonas species have
been implicated for most causative organisms [1,4]. After
the era of antibiotics, the epidemiology of this disease is
changing. Bacteroides fragilis was reported as a rare causa-
tive pathogen. We describe a case of B. fragilis aortic arch
mycotic pseudoaneurysm in a female patient who pre-
sented with fever of unknown origin (FUO).
Case report
A 58-year-old woman with diabetes mellitus, hepatitis C
virus-related liver cirrhosis, and total hysterectomy for
uterine myoma was admitted to another hospital because
of a one-month history of recurrent fevers. Blood cultures
were all negative, and a CT scan of the abdomen and pel-
vis was unremarkable. After a week of intravenous antibi-
otic treatment, she still presented with mild fever. Owing
to that persisted intermittent low-grade fever, she was
transferred to our institution and admitted for her fever
cause surveying.
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precordial area while coughing in recent one week. Her
initial vital signs revealed a high fever up to 39.5°C, blood
pressure of 140/88 mmHg, heart rate of 115 beats/min,
and tachypnea of 28/min. The physical examinations
were remarkable only for pale conjunctivae and crackles at
the right lung base. Laboratory studies showed leukocyto-
sis of WBC count 11,800/μL (74% neutrophils, 13% band
forms, 7% lymphocytes, 5% monocytes, and 1%
basophils); hemoglobin level 10.8 g/dL; and platelet
count 102,000/μL. The C-reactive protein concentration
was 182 mg/L. Electrolyte levels and renal function test
results were within normal limits. The chest radiography
revealed a mildly widened mediastinum with bilateral
blurred costovertebral angles. Chest and abdominal com-
puted tomography disclosed a mycotic pseudoaneurysm
originating from the aortic arch with upper mediastinitis
(Fig. 1). The transthoracic echocardiogram revealed no
evidence of infective endocarditis. Empirical treatment
with cefotaxime and teicoplanin was administrated
parenterally, and she was transferred to the intensive care
unit for further care. The immediate aorta-coronary angi-
ogram survey also confirmed an aortic arch aneurysm
with normal coronary vessels. Suddenly, she was noted
with paradoxical pulse on the blood pressure monitor.
Owing to exacerbation of dyspnea, accumulation of mas-
sive left pleural effusion with tracheal deviation to the
right side, and an enlarged heart shadow on the follow-up
chest roentgenogram, the patient received an emergent
operation under the suspicion of ruptured mycotic pseu-
Axial CT scansFigure 1
Axial CT scans. (A, B) Images of upper mediastinum show pseudoaneurysm with periaortic infiltration (white arrow).
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thermia and circulatory arrest with superior vena cava
retrograded brain protection. A ruptured mycotic pseu-
doaneurysm in the arch region (apparent orifice between
the innominate artery and the left common carotid
artery), diffuse mediastinal abscess, and pericardial effu-
sion were found at operation. Ascending aorta-to-aortic
arch prosthetic graft interposition (Meadox™ Hemashield®
collagen graft) with innominate artery reimplantation
were performed smoothly. Later, her blood cultures and
resected tissue cultures all yielded B. fragilis were noticed,
so the antibiotic regimen was adjusted according to the
microbiological results. However, progressive jaundice
with hepatic function impairment developed after sur-
gery. Hemodynamic instability due to paroxysmal atrial
fibrillation and rapid ventricular response and deteriora-
tion of consciousness occurred later. Intermittent low-
grade fever developed again. Repeated blood cultures on
postoperative day 10 revealed Candida albicans, and then
amphotericin B was prescribed. Even though under inten-
sive management and antimicrobial therapy, her hepatic
and renal function continued to deteriorate and she died
of multiple organ failure on postoperative day 14.
Discussion
Although the first reported mycotic aneusym was intro-
duced in 1885 by Sir Willam Osler for fungal vegetations
in the aortic arch complicated by endocarditis, mycotic
aneurysm remains one of the most life-threatening condi-
tions in the field of vascular surgery. The prevalence of the
mycotic type among all forms of aortic aneurysm is esti-
mated about 1–2.7% [1,5]. The most common infection
sites are the femoral artery and abdominal aorta, followed
by the thoracoabdominal and thoracic aorta [1,6]. Essen-
tially, three mechanisms of mycotic aortic aneurysm have
been implicated, namely, septic embolization that usually
is secondary to bacterial endocarditis; direct or lymphatic
spread from an adjacent infected focus; and hematoge-
nous seeding of the arterial wall during bacteremia from a
distant focus [1,3,4].
B. fragilis is one of the normal floras in human terminal
ileum, colon, and vagina, but it is also a major anaerobic
pathogen to cause serious infections and attribute to high
mortality if the normal intestinal mucosal is breached,
especially in man. Our patient presented with episodes of
fever that were suppressed with antibiotic therapy but
recurred quickly once treatment was withdrawn. She had
undergone vaginal total hysterectomy for uterine myoma
complicated by pelvic abscess formation 11 months ago.
Although abscess had been drained, we believed this
lesion might be the source of the Bacteroides bacteremia.
In spite of mycotic aneurysms have been well described in
literatures, an aneurysm infected solely with B. fragilis is
unusual. In the literatures, there are total only nine case
reports of a similar process with variant locations, clinical
presentations and possible etiologies [7-13] (Table 1).
Summary from their demography, mostly, this disease
happens on men, except for our patient. Most of them
were pseudoaneurysm except one, when diagnosed. An
thoracic mycotic aneurysm usually is suspected only when
mediastinum widening is found on a chest film or inci-
dentally during a survey CT scan [1,14]. Even under
aggressive anaerobic cultures there still may miss a signif-
icant number of bacteremias like this strain and owing to
there are no significant clinical findings that are pathog-
nomonic of this disease and the laboratory studies usually
show nonspecific results, diagnosis is often delayed.
The conventional strategy for the treatment of mycotic
aneurysm is prompt surgical intervention followed by
long term antibiotic therapy, which is essential to control
systemic sepsis and to achieve cardiovascular stability.
Antibiotics alone are not sufficient, and complete excision
of the affected aorta is the key to curative treatment
[1,10,14]. However, the surgical procedures are associated
with substantial mortality rates associated with the risk of
recurrent infection and the survival was influenced not by
the type of reconstruction but by the status of aneurismal
rupture [11]. The use of homograft, antibiotic-coated
grafts to reduce the source of infection, or of a coated
Table 1: Reported cases of mycotic aneurysm infected by Bacteroids fragilis
Author, year Age, Sex Lo Clinical 
presentation
F* Possible etiology Find-ing Surgery Results
Present case 58, F Arch FUO Y Pelvic abscess PA Graft Expired, 14 days
Beland, 2005 65, M Da Hemoptysis N Diverticulitis, leprosy PA EVAR Survived
Tsuji 2003 74, M Iliac Chronic back pain N Osteomyolitis PA Survived
Matsuyama 2003 69, M Da Sudden back pain N Cholecystitis PA Survived
Doita 2001 60, M Aa Low back pain N Pyogenic 
osetomyolitis
PA Survived
O'Donnell 1999 71, M Aa FUO Y Unknown SA Yes, ND Expired, on table
Jewkes 1989 58, M Aa Abdominal pain Y Appendiceal abscess SA Extra anatomic bypass Survived
Sheehan 1983 53, M Aa Pulsatile mass Y Translumbar 
aortography
PA Laparotomy Expired
Aa: abdominal aorta; Da: descending aorta; FUO: fever of unknown origin; ND: not described; PA: pseudoaneurysm; SA: saccular aneurysmPage 3 of 4
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endoprosthesis to release antibiotics into the blood
stream, have been proposed for the successful manage-
ment [15]. However, it depends on the availability of hos-
pital. Several authors advocated for endovascular stent-
graft treatment with no mortality in small case reports
[15]. The main advantages of this minimally invasive
approach are the reduction of surgical trauma as well as
minimal hemodynamic alterations. It may ultimately
become the standard of care if results prove equivalent to
open intervention. Even though, the difficult application
in ascending aorta to arch region, the possibility of stent
graft infection, and the unaffordable product prices are
major considerations for their usage. In addition, fever
presentation (3/4,75%), indicated active process per-
sisted, in such patients seems a terrible signature for most
of patients would have poor prognosis even under aggres-
sive treatment.
In conclusion, it should be noted that Bacterioides fragilis
is a rare causative pathogen and the primary source of this
bacterium is often undetermined. A higher clinical aware-
ness of this disease, leading to early computed tomogra-
phy evaluation and prompt surgical intervention under
appropriate and intensive antibiotic therapy, appears to
offer the best chance of survival in patients with this diffi-
cult condition.
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